Snapshot · HCA Healthcare, Inc. (HCA)

Data as of 2026-08-30T15:35:02.830Z

Fundamentals check

Market cap

$90.5B

P/E (TTM)

13.9

Gross margin

28.4%

Net margin

8.8%

ROE

-112.9%

R&D / revenue

0.0%

Dividend yield

0.7%

FCF yield

6.6%

Latest dividend: $0.78/share (ex-date 2026-09-16, quarterly)

Summary

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

How it makes money

Revenue mix, latest fiscal year

• Managed Care And Other Insurers50.5%
• Managed Medicare18.4%
• Medicare15.4%
• Medicaid8.1%
• Managed Medicaid5%
• International2.5%

Recent Events

• 2026-08-25T07:20:00.000Zpositive

  HCA DCF Analysis: Intrinsic Value $785 vs Price $429

  可能与对比估值分析结果相关，显示当前价格低于DCF估值，存在潜在投资机会，但不构成明确买入信号。

  Source: gurufocus.com

• 2026-08-24T04:03:55.000Zneutral

  Bank of Nova Scotia Invests $18.47 Million in HCA Healthcare, Inc. $HCA

  或有助于理解机构持仓变化，可能与股价短期波动相关，但不表明因果关系。

  Source: defenseworld.net

• 2026-08-22T03:51:45.000Zneutral

  10,563 Shares in HCA Healthcare, Inc. $HCA Bought by B. Metzler seel. Sohn & Co. AG

  可能与机构买入活动相关，影响供需平衡，非因果断言。

  Source: defenseworld.net

• 2026-08-22T03:05:31.000Zneutral

  Advisors Capital Management LLC Buys Shares of 6,507 HCA Healthcare, Inc. $HCA

  可能与机构投资活动相关，提示短期需求变动，但不确定长期影响。

  Source: defenseworld.net

• 2026-08-21T00:00:00.000Zpositive

  Price move: HCA rose 5.6%

  HCA 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-08-20T16:30:00.000Zneutral

  HCA Healthcare, Inc. to Present at September Conferences

  恰逢公司参与演示会，或与信息披露及投资者关注度相关，非直接因果。

  Source: businesswire.com

• 2026-08-19T06:41:07.000Zpositive

  13,003,600 Shares in HCA Healthcare, Inc. $HCA Acquired by BlackRock Inc.

  可能与重大机构增持相关，短期行情可能受益，但不表示因果结论。

  Source: defenseworld.net

• 2026-08-18T07:27:00.000Zpositive

  Is HCA Undervalued? DCF Says Worth $785

  恰逢市场对DCF评估的讨论，可能与估值偏低有关，但尚需考虑多因素影响，非确定性结论。

  Source: gurufocus.com

• 2026-08-06T08:30:00.000Zneutral

  HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

  恰逢管理层变动，可能与公司治理与运营结构调整相关，但不直接确定业绩影响。

  Source: businesswire.com

• 2026-08-04T23:29:00.000Zneutral

  HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm

  或有助于理解潜在诉讼风险，可能引发不确定性，但不直接断定结果。

  Source: GlobeNewswire Inc.

• 2026-07-29T00:00:00.000Zneutral

  HCA filed 8-K

  重要事件披露，可能与公司更新相关，但需结合其他信息共同判断，不构成因果断言。

  Source: SEC EDGAR

• 2026-07-28T00:00:00.000Zneutral

  HCA filed 10-Q

  公司季度披露信息，可能影响投资者情绪，属于常规披露，非因果判断。

  Source: SEC EDGAR

• 2026-07-28T00:00:00.000Zpositive

  Price move: HCA rose 7.3%

  HCA 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-14T00:00:00.000Znegative

  Price move: HCA fell 6.9%

  HCA 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-02T00:00:00.000Zpositive

  Price move: HCA rose 4.4%

  HCA 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-18T00:00:00.000Znegative

  Price move: HCA fell 3.3%

  HCA 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-09T00:00:00.000Zpositive

  Price move: HCA rose 3.8%

  HCA 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $445 from 18 analysts (last quarter)

Insider & Congress activity

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。